Adam Bisaga & Edward V. Nunes. NIDA UH3. Evaluation of Safety and Pharmacokinetics of Naltrexone Implant.
Adam Bisaga. NIDA U01. Efficacy of Buprenorphine and XR-naltrexone Combination for Relapse Prevention in Opioid Use Disorder.
Aimee Campbell (Sub-PI). NIDA P30. Technology-based Treatments for Substance Use Disorders.
Aimee Campbell (Sub-PI). NIDA R25. Translational Research Training on Addictions for Racial/Ethnic Minorities.
Aimee Campbell (Sub-PI). NIDA R44. A Game-based Intervention for Opioid Use Disorder.
Aimee Campbell (Sub-PI). NIDA UM1. CHASE: An Innovative County-Level Public Health Response to the Opioid Epidemic in New York State.
Alissa Davis. NICHD R21. JasSpark study: Reducing HIV Stigma to Increase HIV Testing Among Adolescents and Young Adults in Kazakhstan Using a Crowdsourcing Approach.
Andrea Norcini Pala. CHOSEN Micro-grant. Culturally Tailored Community Engagement Intervention for Naloxone and MOUD Engagement for African Americans under community Supervision in New York City. An Adaptation.
Andrea Norcini Pala. NIMH K01. A Behavioral Intervention for Black MSM and Live with HIV to Address Intersectional Stigma and Improve Antiretroviral Therapy Adherence.
Andrea Norcini Pala. NIMH R01. Evaluation of Neurobiological Mechanisms Mediating the Effect of Immune Activation on Neurocognitive Impairment and the Role of Psychosocial Factors Among Women Living with HIV.
Anindita Dasgupta. NIAAA R01. WINGS + PrEP. A syndemic mHealth intervention to increase PrEP uptake among women impacted by heavy alcohol use and partner violence in the criminal legal system.
Arthur R. Williams & Scott Hadland (MPI). NIDA R01. Identifying Disparities in the Cascaid of Care for Medicaid-Enrolled Youth with Opioid Use Disorder.
Arthur Robin Williams. SAMHSA sub-award. Clinical Decision Support Tools for OBOT.
Arthur Robin Williams R01 DA059042-01. 6/01/2023 -3/31/2028 NIDA “The OUD Cascade of Care and Critical Outcomes: Longitudinal Linkage with Opioid Use” Role: Principal Investigator (PI)
Arthur Robin Williams, Hadland R01 DA057566-01. 9/01/2022 - 8/31/2027 NIDA “Identifying Disparities in the Cascade of Care for Medicaid-Enrolled Youth with Opioid Use Disorder” Role: Principal Investigator (MPI)
Bernard Chang (MPI). NHLBI R01. The Identification of Modifiable Emergency Department and Sleep Factors Contributing to Psychological and Cardiovascular Risk in Clinicians.
Brooke West. NIDA and Fogarty R01. Reducing Intersectional and HIV Stigma among High-Risk Women who use Drugs in Kazakhstan, Central Asia: A Multilevel Stigma Resistance and Enacted Stigma Reduction Intervention for Women and Providers.
Caroline A. Arout & Margaret Haney (MPI). NIDA R01. Repeated Administration of Cannabis Varying in THC and CBD: Effects on Abuse Liability, Experimental Pain and Plasma Endocannabinoids.
Caroline A. Arout. CHOSEN Micro-grant. Evaluating the Role of Chronic Cannabis Use on Perioperative Outcomes.
Christina Brezing. NIDA R21. A Randomized, Controlled Trial of Sublingual Buprenorphine through Telemedicine vs In-Person Care as Usual in the Treatment of Opioid Use Disorder.
Dawn A. Goddard-Eckrich. NIDA HCS Substudy. Equity in Access: Naloxone, MOUD and COVID-19 Services - New York State Pharmacy/Pharmacists Study.
Derek Blevins. SAMHSA sub-award. Integrating Screening and Brief Interventions for Stimulant Use During Buprenorphine Treatment for OUD in Primary Care.
Diana Martinez. NIDA K24. From the Scanner to the Clinic: Patient Oriented Research and Mentorship.
Diana Martinez. SAMHSA sub-award. Mental Health and Drug Use: A Program for High Schools.
Edward V. Nunes, Katherine S. Elkington, & Milton L. Wainberg (MPI). NIDA JCOIN UG1. Evaluation of safety and pharmacokinetics of naltrexone implant
Frances R. Levin (Sub-PI, Medical Director). SAMHSA. FY Opioid State Targeted Response Technical Assistance (STR-TA).
Frances R. Levin (Sub-PI; Medical Director). SAMHSA. SOR-CARE-41 States Technical Assistance Team Education and Support- Provider Clinical Support System.
Frances R. Levin (Sub-PI). NIDA R25. Translational Research Training on Addictions for Racial/Ethnic Minorities.
Frances R. Levin & Sandra D. Comer (MPI). NIDA UG3. Phase 1 and 2 Studies of Sublingual Dexmedetomidine, an alpha-2-adrenergic agonist, for treating opioid withdrawal.
Frances R. Levin. NIDA R21. Randomized controlled trial of extended-release buprenorphine vs. sublingual buprenorphine for the treatment opioid use disorder patients using fentanyl analogues.
Frances R. Levin. NIDA T32. Translational Clinical Research Fellowship on Substance Use Disorders.
Frances R. Levin. NIDA U01. Advancement of AEF0117 as a potential treatment for Cannabis Use Disorder: Preclinical toxicity and Clinical pharmacokinetic studies.
Jermaine Jones (PI). NIDA R21. The Ability of the Inhaled Dronabinol to Reduce the Severity of Naloxone-Precipitated Withdrawal.
Jermaine Jones (PI). NIDA R34. Church-Tailored Opioid Overdose Education and Naloxone Distribution to Target Overdose and Stigma Among African-American Communities.
John Mariani. NIAAA R21. Pregabalin Treatment of Alcohol Use Disorder.
Karli Hochstatter. NIDA R01. Identifying Suspected Drug Overdose Deaths in Near Real-Time Using Data Collected by Death Investigators.
Margaret Paschen-Wolff & Jeremy Kidd (MPI). SAMHSA sub-award. Disseminating Evidence-based Treatment for Men Who Have Sex with Men (MSM) with Methamphetamine Use Disorder (MethUD).
Melissa Slavin. NIDA K01. Adaptation of a Digital Group-Based Intervention to Reduce Drug Use and Increase Contraceptive Use among Reproductive-Aged Women Involved in Criminal Justice.
Michael Chaple, Kelliw Bryant, & Jermaine Jones (MPI). SAMHSA sub-award. Wound Assessment and Referral Protocol (WARP) for People Who Use Drugs (PWUD).
Nabila El-Bassel & Elwin Wu (MPI). NIMH R25. HIV Intervention Science Training Program for Underrepresented Investigator.
Nabila El-Bassel & Lisa R. Metsch (MPI). NIDA T32. Training Program on HIV and Substance Use in the Criminal Justice System.
Nabila El-Bassel & Victoria Frye (MPI). NIDA R34. Peer-based HIV Self-testing among High Risk Women Who Inject or Use Drugs in Kazakhstan, Central Asia.
Nabila El-Bassel, Louisa Gilbert, Daniel J. Feaster, & Edward V. Nunes (MPI). NIDA UM1. CHASE: An Innovative County-Level Public Health Response to the Opioid Epidemic in New York State.
Sandra D. Comer & Marco Pravetoni (MPI). NIDA UG3. Development of a Monoclonal Antibody to Reverse Overdose from Fentanyl and its Analogs: From Manufacturing to Clinical Trials.
Sandra D. Comer, Gretchen L. Snyder, & Dean Foster Wong (MPI). NIDA UG3. Development of ITI-333, a μ-opioid Receptor Partial Agonist and 5HT2A and D1 Receptor Antagonist, for the Treatment of Opioid Use Disorders.
Sandra Springer, Kathleen T. Brady, Frances R. Levin & Edward V. Nunes (MPI). NCATS U01. Coordinated medical treatment of opioid use disorder and infectious disease.
Tim Hunt. SAMHSA funding with NYSPI study. Elevating Social Work's Role (implementation study) in the Multidisciplinary Approach to Substance Use Disorder Treatment: Engagement in and Across Systems.
Tonisha Kearny-Ramos. NIDA K01. Imaging the Effects of Intermittent Thetaburst Stimulation on Cannabis Self-Administration in Heavy Cannabis Users.
